Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study

Second-line treatment of endometrial cancer is an unmet medical need. Lurbinectedin showed promising antitumor activity in a phase I study in combination with doxorubicin in advanced endometrial cancer. This phase 2 Basket trial evaluated lurbinectedin 3.2 mg/m(2) 1-h intravenous infusion every 3 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristeleit, Rebecca, Leary, Alexandra, Delord, Jean Pierre, Moreno, Victor, Oaknin, Ana, Castellano, Daniel, Shappiro, Geoffrey I., Fernández, Cristian, Kahatt, Carmen, Alfaro, Vicente, Siguero, Mariano, Rueda, Daniel, Zeaiter, Ali, Awada, Ahmad, Santaballa, Ana, Zaman, Khalil, Sehouli, Jalid, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560193/
https://www.ncbi.nlm.nih.gov/pubmed/37556023
http://dx.doi.org/10.1007/s10637-023-01383-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560193/
https://www.ncbi.nlm.nih.gov/pubmed/37556023
http://dx.doi.org/10.1007/s10637-023-01383-2

Ejemplares similares